Iva Selke Krulichová

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 71 citations · Full text

Pharmaceutical policy in Italy: towards a structural change?

Simone Ghislandi, Iva Selke Krulichová, Livio Garattini · Health Policy · 2004 · 60 citations

Pharmaceutical Innovation, Health Policy, Pharmacy +9

Pain in primary care: an Italian survey

Daniela Koleva, Iva Selke Krulichová, Guido Bertolini et al. · European Journal of Public Health · 2005 · 59 citations · Full text

Comparison of drug prescribing before and during the <scp>COVID</scp>‐19 pandemic: A cross‐national European study

Iva Selke Krulichová, Gisbert Selke, Marion Bennie et al. · Pharmacoepidemiology and Drug Safety · 2022 · 46 citations · Full text

Tolerability and Outcomes of Kinetically Guided Therapy With Gentamicin in Critically Ill Neonates During the First Week of Life: An Open-Label, Prospective Study

Jiřina Martı́nková, Pavla Pokorná, Jiří Záhora et al. · Clinical Therapeutics · 2010 · 32 citations

Critical Care Medicine, Kinetically Guided Therapy, Neonatology +8